![Thierry Abribat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thierry Abribat was the founder of Millendo Therapeutics SAS, founded in 2007, serving as President & Chief Executive Officer from 2007 to 2010.
Dr. Abribat was the founder of Amolyt Pharma SAS, founded in 2014, serving as Chief Executive Officer & Director from 2014 to 2024.
Former jobs include Chief Executive Officer at EUSA Pharma SAS in 2007, Director at Millendo Therapeutics US, Inc., Chief Scientific Officer & EVP-Business Development at Theratechnologies, Inc., and Scientist at Sanofi.
Education includes a doctorate from Institut National Polytechnique de Toulouse.
| Unternehmen | Position | Ende |
|---|---|---|
Amolyt Pharma SAS
 Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Gründer | 01.07.2024 |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Vorstandsvorsitzender | 01.01.2007 |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Direktor/Vorstandsmitglied | - |
| THERATECHNOLOGIES INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| SANOFI | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 7 |
|---|---|
Theratechnologies, Inc.
 Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Institut National Polytechnique de Toulouse
 Institut National Polytechnique de Toulouse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Provides pharmaceutical research services | Health Technology |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Health Technology |
Amolyt Pharma SAS
Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
